Interfering with the Ubiquitin-Mediated Regulation of Akt as a Strategy for Cancer Treatment

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• The serine/threonine kinase Akt plays a critical role in cell proliferation, growth, metabolism, angiogenesis, hypoxia resistance, and migration.
• Aberrant Akt signaling, through overexpression or abnormal activation, is frequently observed in human cancers, promoting cancer cell proliferation and survival.

Purpose of the Study:

• To review the functions and roles of Akt in human cancers.
• To focus on molecules and compounds targeting ubiquitination processes regulating Akt activation and inactivation.
• To discuss the therapeutic implications of targeting Akt ubiquitination for cancer treatment.

Main Methods:

• Review of existing literature on Akt signaling pathways.
• Analysis of studies investigating ubiquitination processes (K63-linked and K48-linked) affecting Akt.
• Examination of therapeutic strategies targeting the ubiquitin-proteasome system in cancer.

Main Results:

• Akt deregulation is a hallmark of many human cancers, contributing to increased cancer cell proliferation and survival.
• Interfering with K63-linked ubiquitination or enhancing K48-linked polyubiquitination are potential strategies to inhibit Akt function.
• Targeting the ubiquitin proteasome system has shown efficacy in certain cancer treatments.

Conclusions:

• Modulating Akt ubiquitination presents a promising therapeutic avenue for cancer treatment.
• Targeting specific ubiquitination events offers a novel approach to control Akt activity in cancer.
• Further research into Akt ubiquitination modulators could lead to effective cancer therapies.